2nd Quarter - Report

SNAC INTERNATIONAL for SNAC INTERNATIONAL

Firm
Client
Income
—
Expenses
$15,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Transportation TRA

FMCSA Driver Entry Level Training Requirements Hours of Service Appropriations Language Fleet Safety Fitness Determination Rating

LobbyistCovered position, as disclosed
DAVID WALSH —

Contacted: HOUSE OF REPRESENTATIVES; Federal Motor Carrier Safety Administration; SENATE; Food & Drug Administration (FDA)

Agriculture AGR

Issues impacting the snack food industry, such as nutrition issues such as sodium policy, and issues related to labeling. Supplemental Nutrition Assistance Program (SNAP) as it relates to preserving choice Genetically Modified Organism (GMO) labeling (S. 2609) sponsored by Senator Pat Roberts and S. 764, the Roberts-Stabenow Agreement. Appropriations legislation. Budget.

LobbyistCovered position, as disclosed
DAVID WALSH Director of Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Motor Carrier Safety Administration; Food & Drug Administration (FDA)

Bills named: S. 764 (114th), S. 2609 (114th)

Food Industry (safety, labeling, etc.) FOO

Genetically Modified Organism (GMO) labeling (S. 2609) sponsored by Senator Pat Robert and S. 764, the Roberts-Stabenow Agreement. Dietary Guidelines for Americans FDA Vending Labeling Rule Sodium Public Comments on definition of the term "Natural" to the FDA

LobbyistCovered position, as disclosed
DAVID WALSH —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Motor Carrier Safety Administration; SENATE

Bills named: S. 764 (114th), S. 2609 (114th)

Labor Issues/Antitrust/Workplace LBR

Issues surrounding the National Labor relations Board and the impact on employers. H.R. 1893, S. 933 S. 288, H.R. 1767.

LobbyistCovered position, as disclosed
DAVID WALSH —

Contacted: SENATE; Federal Motor Carrier Safety Administration; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1767 (114th), H.R. 1893 (114th), S. 933 (114th), S. 288 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.